These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14693257)

  • 21. Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies.
    Greenfield L; Burgdorf K; Chen X; Porowski A; Roberts T; Herrell J
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):537-50. PubMed ID: 15540492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment.
    Hoffman KA; Ford JH; Choi D; Gustafson DH; McCarty D
    Drug Alcohol Depend; 2008 Nov; 98(1-2):63-9. PubMed ID: 18565693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between the Dimensions of Change Instrument and retention in therapeutic community treatment: the moderating influence of time in treatment.
    Miles JN; Wenzel S; Mandell W
    Am J Drug Alcohol Abuse; 2008; 34(6):667-72. PubMed ID: 18850499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distance traveled and cross-state commuting to opioid treatment programs in the United States.
    Rosenblum A; Cleland CM; Fong C; Kayman DJ; Tempalski B; Parrino M
    J Environ Public Health; 2011; 2011():948789. PubMed ID: 21776440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-user treatment programs in a large metropolitan area.
    Polinsky ML; Hser YI; Anglin MD; Maglione MA
    Subst Use Misuse; 1998 Jun; 33(8):1735-61. PubMed ID: 9680091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in access to outpatient substance abuse treatment: organizational factors and conceptual issues.
    McCaughrin WC; Howard DL
    J Subst Abuse; 1996; 8(4):403-15. PubMed ID: 9058353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients.
    Edelen MO; Tucker JS; Wenzel SL; Paddock SM; Ebener P; Dahl J; Mandell W
    J Subst Abuse Treat; 2007 Jun; 32(4):415-21. PubMed ID: 17481465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Program and client characteristics as predictors of the availability of social support services in community-based substance abuse treatment programs.
    Delany PJ; Shields JJ; Roberts DL
    J Behav Health Serv Res; 2009 Oct; 36(4):450-64. PubMed ID: 19082738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transportation and retention in outpatient drug abuse treatment programs.
    Friedmann PD; Lemon SC; Stein MD
    J Subst Abuse Treat; 2001 Sep; 21(2):97-103. PubMed ID: 11551738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with pretreatment and treatment dropouts: comparisons between Aboriginal and non-Aboriginal clients admitted to medical withdrawal management.
    Li X; Sun H; Marsh DC; Anis AH
    Harm Reduct J; 2013 Dec; 10():38. PubMed ID: 24325629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment.
    Laudet AB; Stanick V; Sands B
    J Subst Abuse Treat; 2009 Sep; 37(2):182-90. PubMed ID: 19339133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early drop-outs and retentions in substance abuse outpatient clinics: a cross-sectional comparative study of factors that increase or decrease adherence].
    Calvo F; Carbonell X; Valero R; Costa J; Turró O; Giralt C; Ramírez M
    Aten Primaria; 2018 Oct; 50(8):477-485. PubMed ID: 28843489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of an outpatient program for women with substance use-related disorders on retention.
    Zilberman ML; Tavares H; Andrade AG; El-Guebaly N
    Subst Use Misuse; 2003 Dec; 38(14):2109-24. PubMed ID: 14677784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Client-reported reasons for non-engagement in drug and alcohol treatment.
    Coulson C; Ng F; Geertsema M; Dodd S; Berk M
    Drug Alcohol Rev; 2009 Jul; 28(4):372-8. PubMed ID: 19594791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Mueser KT; Drake RE
    Drug Alcohol Rev; 2004 Dec; 23(4):471-81. PubMed ID: 15763752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Who cares for involuntary clients?
    Soliman S; Pollack HA; Alexander JA
    Subst Abus; 2009; 30(1):1-13. PubMed ID: 19197777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harlem service providers' perceptions of the impact of municipal policies on their clients with substance use problems.
    van Olphen J; Freudenberg N
    J Urban Health; 2004 Jun; 81(2):222-31. PubMed ID: 15136656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.